Lacosamide extended release capsule- Adamas PharmaceuticalsAlternative Names: ADS 4101; Lacosamide extended release capsule
Latest Information Update: 11 Jan 2017
At a glance
- Originator Adamas Pharmaceuticals
- Class Acetamides; Analgesics; Antiepileptic drugs; Neuroprotectants; Small molecules
- Mechanism of Action CRMP2 protein modulators; Glycine NMDA-associated antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Epilepsy